Your Article Summary
PhRMA Statement on Appointment of White House Health Czar
PhRMA, 03/03/09
Pharmaceutical Research and Manufacturers of America President and CEO Billy Tauzin issued the following statement regarding Nancy-Ann DeParle's selection to head the White House Office of Health Reform: “Nancy-Ann DeParle certainly brings a lot to the table with her breadth of experience in healthcare issues. Her appointment today complements the nomination of Governor Kathleen Sebelius as Secretary of the Department of Health and Human Services.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Astellas hires new vice president of compliance
Astellas, 09/11/09
Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
Myriad, 09/22/09
Sanofi-aventis announces changes to Executive Committee
Sanofi-aventis, 11/04/09
Article Search
Sponsor


See Latest Articles


